This article is a US government work and, as such, is in the public domain in the United States of America.
A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) μ-opioid agonists on cellular markers related to opioid tolerance and dependence†
Version of Record online: 6 DEC 2006
Published 2006 Wiley-Liss, Inc.
Volume 61, Issue 3, pages 166–175, March 2007
How to Cite
Xu, H., Partilla, J. S., Wang, X., Rutherford, J. M., Tidgewell, K., Prisinzano, T. E., Bohn, L. M. and Rothman, R. B. (2007), A comparison of noninternalizing (herkinorin) and internalizing (DAMGO) μ-opioid agonists on cellular markers related to opioid tolerance and dependence. Synapse, 61: 166–175. doi: 10.1002/syn.20356
- Issue online: 6 DEC 2006
- Version of Record online: 6 DEC 2006
- Manuscript Accepted: 29 OCT 2006
- Manuscript Received: 8 JUN 2006
- NIH (Intramural Research Program)
- National Institute on Drug Abuse. Grant Numbers: R01 DA018151-01A2, R01 DA12970
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!